|
Suppliers for CAS
477600-75-2
|
Properties | | CAS |
477600-75-2 | | Formula |
C16H20N6O |
|
|
21 Registered suppliers
Simagchem Corporation
P.R.China
Amadis Chemical Company Limited
P.R.China
More details are to be found here
Hangzhou Keying Chem Co., Ltd.
P.R.China
More details are to be found here
Xingrui Industry Co., Limited
P.R.China
More details are to be found here
Hangzhou Meite Industry Co., Ltd (Hangzhou Meite Chemical Co., Ltd)
P.R.China
More details are to be found here
Capot Chemical Co., Ltd.
P.R.China
More details are to be found here
Leap Chem Co., Ltd
P.R.China
Molecular Formula: C16H20N6O
Molecular Weight: 312.3696
HS Code: 29335990
Molecular Formula: C16H20N6O Molecular Weight: 312.37
More details are to be found here
Shanghai Haoyuan Chemexpress Co., Ltd.
P.R.China
Arakato Development Ltd
Hong Kong
FUDAW INDUSTRY LTD
P.R.China
Create Chemical Co., Ltd.
P.R.China
Shandong Lanhai Industry Co.,Ltd.
P.R.China
Hangzhou Zhongqi Chem Co., Ltd
P.R.China
Nantong Xindao Biotech Ltd
P.R.China
Finetech Industry Limited
P.R.China
More details are to be found here
Skyrun Industrial Co., Ltd.
P.R.China
More details are to be found here
BOC Sciences
USA
Description : Tofacitinib is an orally available JAK3 inhibitor (IC50 = 1 nM), exhibiting 20- and 100-fold less potency against JAK2 and JAK1. Tofacitinib induces G1 cell cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells. It is approved for the treatment of rheumatoid arthritis (RA). - Molecular Weight :312.37
- Purity :> 98%
Molecular Formula : C16H20N6O Canonical SMILES : CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N InChI : InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1
InChIKey :
UJLAWZDWDVHWOW-YPMHNXCESA-N
Synonyms :
Tasocitinib; 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile; CP-690550
More details are to be found here
AK Scientific, Inc.
USA
Description : Tofacitinib is an orally available JAK3 inhibitor (IC50 = 1 nM), exhibiting 20- and 100-fold less potency against JAK2 and JAK1. Tofacitinib induces G1 cell cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells. It is approved for the treatment of rheumatoid arthritis (RA). - Molecular Weight :312.37
- Purity :> 98%
Molecular Formula : C16H20N6O Canonical SMILES : CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N InChI : InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1
InChIKey :
UJLAWZDWDVHWOW-YPMHNXCESA-N
Synonyms :
Tasocitinib; 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile; CP-690550
More details are to be found here
Chemos GmbH & Co. KG
Germany
Description : Tofacitinib is an orally available JAK3 inhibitor (IC50 = 1 nM), exhibiting 20- and 100-fold less potency against JAK2 and JAK1. Tofacitinib induces G1 cell cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells. It is approved for the treatment of rheumatoid arthritis (RA). - Molecular Weight :312.37
- Purity :> 98%
Molecular Formula : C16H20N6O Canonical SMILES : CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N InChI : InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1
InChIKey :
UJLAWZDWDVHWOW-YPMHNXCESA-N
Synonyms :
Tasocitinib; 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile; CP-690550
More details are to be found here
CM Fine Chemicals
Switzerland
Description : Tofacitinib is an orally available JAK3 inhibitor (IC50 = 1 nM), exhibiting 20- and 100-fold less potency against JAK2 and JAK1. Tofacitinib induces G1 cell cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells. It is approved for the treatment of rheumatoid arthritis (RA). - Molecular Weight :312.37
- Purity :> 98%
Molecular Formula : C16H20N6O Canonical SMILES : CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N InChI : InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1
InChIKey :
UJLAWZDWDVHWOW-YPMHNXCESA-N
Synonyms :
Tasocitinib; 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile; CP-690550
More details are to be found here
Santa Cruz Biotechnology, Inc.
USA
Description : Tofacitinib is an orally available JAK3 inhibitor (IC50 = 1 nM), exhibiting 20- and 100-fold less potency against JAK2 and JAK1. Tofacitinib induces G1 cell cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells. It is approved for the treatment of rheumatoid arthritis (RA). - Molecular Weight :312.37
- Purity :> 98%
Molecular Formula : C16H20N6O Canonical SMILES : CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N InChI : InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1
InChIKey :
UJLAWZDWDVHWOW-YPMHNXCESA-N
Synonyms :
Tasocitinib; 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile; CP-690550
More details are to be found here
|
details
details